Your browser is no longer supported. Please, upgrade your browser.
PTE PolarityTE, Inc. daily Stock Chart
PolarityTE, Inc.
Index- P/E- EPS (ttm)-3.76 Insider Own23.40% Shs Outstand42.67M Perf Week-2.55%
Market Cap41.58M Forward P/E- EPS next Y-1.25 Insider Trans-1.67% Shs Float24.73M Perf Month-8.93%
Income-92.50M PEG- EPS next Q-0.52 Inst Own21.60% Short Float16.01% Perf Quarter-67.62%
Sales5.70M P/S7.30 EPS this Y-329.30% Inst Trans0.09% Short Ratio6.52 Perf Half Y-66.51%
Book/sh1.44 P/B0.68 EPS next Y33.20% ROA-131.90% Target Price9.50 Perf Year-89.68%
Cash/sh0.68 P/C1.42 EPS next 5Y15.00% ROE-169.50% 52W Range0.78 - 11.39 Perf YTD-62.52%
Dividend- P/FCF- EPS past 5Y5.60% ROI-226.70% 52W High-91.44% Beta1.88
Dividend %- Quick Ratio3.20 Sales past 5Y-3.30% Gross Margin56.10% 52W Low24.61% ATR0.14
Employees153 Current Ratio3.20 Sales Q/Q114.30% Oper. Margin- RSI (14)33.93 Volatility13.57% 15.27%
OptionableYes Debt/Eq0.06 EPS Q/Q9.40% Profit Margin- Rel Volume0.54 Prev Close0.97
ShortableYes LT Debt/Eq0.03 EarningsMar 17 AMC Payout- Avg Volume607.77K Price0.97
Recom1.80 SMA20-4.25% SMA50-39.17% SMA200-69.56% Volume328,093 Change0.53%
Nov-11-19Resumed Cantor Fitzgerald Overweight $50 → $13
Jul-08-19Initiated H.C. Wainwright Buy $8
Mar-21-19Initiated Evercore ISI Outperform $26
Jan-28-19Initiated Northland Capital Outperform $50
Jan-28-19Initiated National Securities Sell $5
Dec-20-18Initiated Piper Jaffray Overweight
Apr-08-20 08:00AM  PolarityTE Announces Conclusion of SEC Investigation Business Wire +11.17%
Apr-06-20 08:00AM  PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of Directors Business Wire +5.54%
Apr-01-20 08:00AM  PolarityTE Announces Appointment of David Seaburg as CEO and Restructuring of Executive Team Business Wire -12.75%
Mar-15-20 09:26AM  Earnings Release: Here's Why Analysts Cut Their PolarityTE, Inc. Price Target To US$10.17 Simply Wall St.
Mar-12-20 07:00AM  PolarityTE Reports Fiscal Year 2019 Financial Results Business Wire -7.48%
Mar-05-20 08:00AM  PolarityTE to Attend the Oppenheimer 30th Annual Healthcare Conference Business Wire
Mar-03-20 08:00AM  PolarityTE to Report Fiscal Year 2019 Financial Results on March 12, 2020 Business Wire
Feb-18-20 06:38PM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of PolarityTE, comScore, AMC, and Conagra Brands and Encourages Investors to Contact the Firm GlobeNewswire -5.92%
Feb-12-20 09:24AM  PolarityTE's stock loses nearly half its value after public offering of stocks, warrants MarketWatch -47.17%
09:00AM  PolarityTE Announces Pricing of Public Offering of Common Stock and Warrants Business Wire
Feb-11-20 04:01PM  PolarityTE Announces Public Offering of Common Stock and Warrants Business Wire
Dec-19-19 06:29PM  Hedge Funds Are Crazy About PolarityTE, Inc. (PTE) Insider Monkey
Dec-18-19 08:00AM  PolarityTE to Participate in Corporate Access Event in San Francisco, January 13-15, 2020 Business Wire
Dec-12-19 09:11AM  Is the Options Market Predicting a Spike in PolarityTE (PTE) Stock? Zacks
Dec-10-19 08:00AM  PolarityTE Builds Patent Portfolio with New International Patent Grants Business Wire
Dec-06-19 08:00AM  12 Biotech Stocks Primed For A Short Squeeze Benzinga +9.27%
Dec-05-19 08:00AM  PolarityTE Announces Equity Purchase Agreement for up to $25 Million with Keystone Capital Partners Business Wire -12.79%
Nov-28-19 09:42AM  Here's Why We're A Bit Worried About PolarityTE's (NASDAQ:PTE) Cash Burn Situation Simply Wall St.
Nov-27-19 08:00AM  PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference TEST Business Wire Releases
08:00AM  PolarityTE to Attend Evercore ISI 2nd Annual HealthCONx Conference and Piper Jaffray 31st Annual Healthcare Conference Business Wire
Nov-19-19 04:55PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PolarityTE, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Nov-12-19 04:05PM  PolarityTE Reports Third Calendar Quarter 2019 Results Business Wire -11.55%
Nov-07-19 04:01PM  PolarityTE Adopts Short-Term Shareholder Rights Plan Business Wire
Oct-24-19 08:00AM  PolarityTE to Report Calendar Third Quarter Financial Results on November 12, 2019 Business Wire -7.93%
Oct-14-19 03:36PM  PolarityTE, Inc. (NASDAQ:PTE): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
08:00AM  PolarityTE Announces Positive Pilot Study Data of SkinTE as a Treatment for Venous Stasis Leg Ulcers Business Wire
Oct-06-19 10:00AM  Bragar Eagel & Squire is Investigating Certain Officers and Directors of National General Holdings, Natural Health Trends, Omnicell, and Polarity TE and Encourages Investors to Contact the Firm GlobeNewswire
Oct-03-19 08:00AM  SkinTE Data to be Presented at the 19th Annual Diabetic Foot Global Conference Business Wire
Sep-26-19 08:00AM  PolarityTE Selected to Present at 2019 Cell & Gene Meeting on the Mesa Business Wire -8.98%
Sep-23-19 08:00AM  PolarityTE Announces Positive Data Showing SkinTE Regenerated Full-Thickness Skin in Difficult-to-Treat Wounds Business Wire +5.78%
Sep-18-19 08:00AM  PolarityTE to Attend the 2019 Cantor Global Healthcare Conference Business Wire
Sep-16-19 08:00AM  SkinTE Data Including Final Pilot Study Data Readout to be Presented at the Symposium on Advanced Wound Care Fall Meeting Business Wire
Sep-09-19 08:00AM  SkinTE Data to be Presented at the American Society of Plastic Surgeons 88th Annual Scientific Meeting PR Newswire +5.44%
Sep-04-19 08:00AM  PolarityTE Appoints Peter Cohen as Chairman of the Board PR Newswire +8.89%
Aug-28-19 08:00AM  PolarityTE to Attend H.C. Wainwright 21st Annual Healthcare Conference and Morgan Stanley 17th Annual Global Healthcare Conference PR Newswire +18.08%
Aug-20-19 01:43PM  Introducing PolarityTE (NASDAQ:PTE), The Stock That Tanked 80% Simply Wall St.
12:55PM  PolarityTE Granted Canadian Patent PR Newswire
Aug-16-19 08:00AM  PolarityTE to Present at Military Health System Research Symposium on Platform Technology for Treatment of Traumatic and Chronic Wounds PR Newswire
Aug-08-19 07:00AM  PolarityTE Reports Second Calendar Quarter 2019 Results PR Newswire +19.44%
Jul-25-19 08:00AM  PolarityTE to Report Calendar Second Quarter Financial Results on August 8, 2019 PR Newswire
Jul-24-19 09:35AM  PolarityTE Enters Oversold Territory Zacks
Jun-29-19 07:17PM  Is PolarityTE, Inc. (PTE) A Good Stock To Buy ? Insider Monkey
Jun-19-19 12:30PM  What Type Of Shareholder Owns PolarityTE, Inc.'s (NASDAQ:PTE)? Simply Wall St.
Jun-12-19 11:49AM  Weekly CFO Buys Highlight
Jun-10-19 10:09AM  PolarityTE Shares Rally On Positive Readout From Skin Graft Study In Diabetic Foot Ulcers Benzinga
08:00AM  PolarityTE Announces Final Clinical Data from Pilot Study Showing Closure of Diabetic Foot Ulcers Using SkinTE PR Newswire
Jun-08-19 05:38PM  Ready Trader One: Events, Stocks To Watch At E3 Benzinga
Jun-03-19 08:00AM  PolarityTE Creates Office of the Chief Executive to Focus on Commercialization and Operational Performance PR Newswire
May-31-19 01:33PM  Analysts Recommend These 3 Falling Knives
May-21-19 08:00AM  Final Data from Pilot Study on Use of SkinTE for Diabetic Foot Ulcers Accepted as Late-Breaking Abstract at the American Diabetes Association's 79th Scientific Sessions Conference PR Newswire
May-20-19 11:26AM  Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks -9.79%
May-10-19 09:55AM  3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates Zacks
07:30AM  PolarityTE Announces Clinical Data from Two Studies Showing 12-Week Closure of Difficult-to-Treat Lower Extremity Chronic Wounds Using SkinTE PR Newswire
07:16AM  PolarityTE Reports First Calendar Quarter 2019 Results PR Newswire
May-02-19 09:00AM  Should You Be Concerned About PolarityTE, Inc.'s (NASDAQ:PTE) Historical Volatility? Simply Wall St. +6.72%
May-01-19 08:00AM  PolarityTE to Report Calendar First Quarter Financial Results on May 10, 2019 PR Newswire
Apr-24-19 08:00AM  SkinTE Clinical Data to be Presented, PolarityTE to Host Booth and SkinTE Event at Symposium on Advanced Wound Care (SAWC) Spring, Wound Healing Society Meeting PR Newswire
Apr-10-19 11:00AM  Why PolarityTE Is Sinking Today Motley Fool -10.18%
09:30AM  PolarityTE Announces Pricing of Public Offering of Common Stock PR Newswire
Apr-09-19 04:01PM  PolarityTE Announces Public Offering of Common Stock PR Newswire
Apr-02-19 04:34PM  Lifshitz & Miller LLP Announces Investigation of Bloom Energy Corporation, First Choice Healthcare Solutions, Inc., Nutanix, Inc., PolarityTE, Inc., Revlon, Inc., Tivity Health, Inc., WellCare Health Plans, Inc., and Whitestone REIT PR Newswire
Apr-01-19 08:00AM  PolarityTE Enrolls First Patients in Two Clinical Trials Evaluating SkinTE for the Treatment of Chronic Wounds PR Newswire
Mar-29-19 08:00AM  PolarityTE Announces Richard Hague, Formerly from Sanofi, Genzyme and Recently Anika Therapeutics as Chief Operating Officer PR Newswire
Mar-27-19 08:00AM  Clinical Outcomes Data on SkinTE from Lower Extremity Chronic Wounds to be Presented at Diabetic Limb Salvage (DLS) Conference PR Newswire
Mar-21-19 08:00AM  PolarityTE Hosts Symposium Featuring SkinTE-Treated Burn Survivor, New Clinical Data at American Burn Association Annual Meeting PR Newswire +9.60%
Mar-19-19 05:00PM  PolarityTE to Present at Oppenheimer 29th Annual Healthcare Conference PR Newswire
02:15PM  RM LAW Announces Investigation of PolarityTE, Inc. PR Newswire
01:06PM  Federman & Sherwood Investigates PolarityTE, Inc. for Possible Violations of Federal Securities Laws Business Wire
10:47AM  PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation of PolarityTE, Inc. - PTE GlobeNewswire
Mar-18-19 07:56PM  Bragar Eagel & Squire, P.C. is Investigating PolarityTE, Inc. (PTE) on Behalf of Stockholders and Encourages PTE Investors to Contact the Firm GlobeNewswire -15.64%
05:40PM  PolarityTE (PTE) Investigation: Bernstein Liebhard LLP Announces Investigation Of PolarityTE, Inc. - PTE PR Newswire
04:20PM  Why PolarityTE Stock Tanked Today Motley Fool
02:16PM  Biotech's shares tumble after it says SEC is looking into possible manipulation CNBC
07:00AM  PolarityTE Reports Results and Corporate Update for Two-Month Transition Period Ended December 31, 2018 PR Newswire
Mar-14-19 10:20AM  Read This Before Buying PolarityTE, Inc. (NASDAQ:PTE) Shares Simply Wall St.
Mar-13-19 08:45AM  PolarityTE to Attend Medlab Asia Pacific and Asia Health 2019 Conferences PR Newswire
Mar-11-19 11:39AM  Why PolarityTE Stock Is Shooting Higher Today Motley Fool +22.25%
10:30AM  Will Polarity (PTE) Report Negative Q1 Earnings? What You Should Know Zacks
Mar-06-19 04:01PM  PolarityTE to Present at the 39th Annual Cowen Healthcare Conference and at the 13th Annual Canaccord Genuity Musculoskeletal Conference PR Newswire
Mar-05-19 08:00AM  Congressional Health Care Innovation Showcase to Feature PolarityTE PR Newswire
Feb-27-19 08:00AM  PolarityTE Presents Platform Technology at Department of Defense Pacific Operational Science and Technology (POST) Conference PR Newswire
Feb-25-19 10:10AM featured expert Kevin Matras highlights: Shenandoah Telecommunications, Honda Motor, PolarityTE, Ubiquiti Networks and Titan Machinery Zacks
Feb-22-19 09:06AM  5 Stocks to Buy as New Analysts Initiate Coverage Zacks
Feb-06-19 07:12AM  PolarityTE, Inc. (NASDAQ:PTE): The Best Of Both Worlds Simply Wall St.
Feb-01-19 11:30AM  LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index ACCESSWIRE
08:00AM  Boswick Burn and Wound Symposium: New Data to be Presented on Preclinical and Clinical Use of SkinTE PR Newswire
Jan-29-19 04:15PM  PolarityTE Names Board Member David Seaburg as President of Corporate Development PR Newswire
Jan-23-19 08:50AM  Implied Volatility Surging for PolarityTE (PTE) Stock Options Zacks
08:00AM  World Stem Cell Summit: PolarityTE to Present Abstract on Regenerative Platform Technology PR Newswire
Jan-14-19 07:00AM  PolarityTE Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
Jan-07-19 08:00AM  PolarityTE Expands Contract Services Business with Addition of Jon Burrows PR Newswire -6.13%
Jan-03-19 08:00AM  PolarityTE to Report Fiscal Fourth Quarter Financial Results on January 14, 2019 PR Newswire
Dec-28-18 08:00AM  PolarityTE Registers OsteoTE with U.S. Food and Drug Administration PR Newswire
Dec-27-18 08:00AM  PolarityTE to Participate in Corporate Access Event in San Francisco, January 7-9, 2019 PR Newswire
Dec-24-18 10:21AM  Investors Are Undervaluing PolarityTE, Inc. (NASDAQ:PTE) By 32.74% Simply Wall St.
Dec-19-18 08:00AM  PolarityTE and University Hospitals Cleveland Medical Center Announce System-Wide Approval of SkinTE PR Newswire +8.85%
Dec-11-18 08:00AM  PolarityTE Announces Former FDA Official and Johnson & Johnson Executive Minnie Baylor-Henry Joins Board of Directors PR Newswire +17.64%
Dec-04-18 08:00AM  PolarityTE to Present SkinTE Clinical Outcomes at Innovations in Wound Healing Conference PR Newswire -7.19%
Nov-29-18 08:00AM  PolarityTE Announces Recognition of SkinTE as Finalist for Fierce Innovation Awards Biotech Innovation PR Newswire
Nov-27-18 07:00AM  PolarityTE Announces Matt Kemp as Chief Commercial Officer PR Newswire
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lough DenverPrior Director and OfficerApr 02Option Exercise0.0011,11107,123,878Apr 03 11:45 AM
Mann Paul ElliotChief Financial OfficerMar 31Sale1.0423,15824,084415,953Apr 02 04:30 PM
Seaburg David BChief Executive OfficerMar 31Sale1.0421,28722,138345,965Apr 02 04:30 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPMar 30Sale1.159361,076323,120Mar 31 08:16 PM
Mann Paul ElliotChief Financial OfficerMar 23Sale1.051,2831,347439,111Mar 25 09:05 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPMar 23Sale1.053,5003,675324,056Mar 25 09:03 PM
Lough DenverPrior Director and OfficerMar 03Option Exercise0.0011,11107,116,001Mar 04 07:08 PM
Seaburg David BPresidentMar 03Sale1.345,4507,303367,251Mar 04 04:30 PM
Hague RichardChief Operating OfficerFeb 07Sale3.0212,95039,109321,895Feb 07 09:32 PM
Mann Paul ElliotChief Financial OfficerFeb 07Sale3.0212,83338,756440,393Feb 07 09:30 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPFeb 07Sale3.0411,66735,468327,556Feb 07 09:28 PM
Seaburg David BPresidentFeb 07Sale3.0216,33349,326372,701Feb 07 09:26 PM
Lough DenverPrior Director and OfficerFeb 04Option Exercise0.0011,11107,108,602Feb 05 10:22 AM
Lough DenverPrior Director and OfficerJan 16Option Exercise3.1210,00031,20010,000Jan 21 06:59 PM
Lough DenverPrior Director and OfficerJan 16Sale4.1710,00041,7000Jan 21 06:59 PM
Lough DenverPrior Director and OfficerJan 03Option Exercise0.0011,11107,097,491Jan 06 03:01 PM
Mann Paul ElliotChief Financial OfficerDec 23Sale2.7111,00029,810453,227Dec 23 08:12 PM
Erdtmann Rainer MDirectorDec 16Sale2.4731,84678,66030,000Dec 17 04:30 PM
Hoyler Cameron J.Gen. Counsel & Exec. VPNov 19Sale3.157,10022,365339,223Nov 22 09:32 AM